GO Capital — 2010 Investments

1 investments dated 2010 · listed companies and verified rows first · show all

Alethia Biotherapeutics Inc.alethiabio.com inSep 2010

Alethia Biotherapeutics is a clinical-stage biotechnology company developing cancer treatments that target tumor resistance by inhibiting the epithelial-mesenchymal transition (EMT) and remodeling the immunosuppressive tumor microenvironment.

BiotechHealthtech

Co-investorsBDC Fund Investments (Fund-of-Funds)BDC Venture Capital BDC Capital Corporation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.